XBIOTECH INC. Interest Payable, Current
XBIOTECH INC. (XBIT) had Interest Payable, Current of $0 as of 2025-12-31, per its 10-K filed 2026-03-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:InterestPayableCurrent · last filed 2026-03-13
- 2025-12-31: Interest Payable, Current $0.00.
- 2024-12-31: Interest Payable, Current $404.00K.
- 2023-12-31: Interest Payable, Current $0.00.
| Period end | Interest Payable, Current |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-13 |
| 2024-12-31 | $404.00K 10-K · filed 2026-03-13 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |